News | Digital Radiography (DR) | March 23, 2022

The mobile exhibition will bring Canon Medical Systems to U.S. cities providing unprecedented access to their solution-focused portfolios

CMSU will bring its state-of-the-art AI medical devices to hospitals and local healthcare providers in a unique hands-on experience to create stronger community engagement throughout the year.

March 23, 2022 — Canon Medical Systems USA, Inc. (CMSU), a global leader in innovative diagnostic imaging technology, is proud to announce its first-ever U.S. mobile tour, Canon Across America, March 24th through December 2, 2022. CMSU will bring its state-of-the-art AI medical devices to hospitals and local healthcare providers in a unique hands-on experience to create stronger community engagement throughout the year.

CMSU’s 50-city mobile tour kicks off in its Tustin, CA headquarters and will travel across the country. The Canon Across America mobile truck tour aims to provide healthcare professionals and hospitals across the U.S. the opportunity to connect with Canon’s innovative solution-focused portfolios at a hands-on level by providing a holistic 360-degree view of their solutions. In addition, Canon will provide live demos, supportive conversations with Canon’s industry experts, and an opportunity to experience the benefits Canon’s platforms offer at their convenience.

"Providing in-person experiences with current and new customers is key for us as a company. It’s a vital opportunity to connect, ask pressing questions in a face-to-face setting, and to learn more about better servicing their needs," said David Hashimoto, Vice President of Marketing and Sales Strategy. “We’re allowing unprecedented access to our technologies to better guide healthcare professionals with the essential information needed to make important decisions about their patients and business.”

Yuji Hamada, President and CEO of Canon Medical Systems USA, agrees. “Canon’s 50-city tour is a unique opportunity for healthcare professionals to gain access to personalized demos. The next generation of medical imaging allows us to provide our customers flexible visits with Canon’s reps and to focus on key areas of interest important to them. We look forward to this year-long journey of meeting our customers, friends, and colleagues and showcasing the very best that Canon has to offer."

For more information: https://us.medical.canon/news/events/across-america-tour/


Related Content

News | Clinical Trials

Aug.12,2026 — Mendaera Inc. has announced results from a peer-reviewed study showing that its FDA-cleared Focalist ...

Time August 17, 2026
arrow
Feature | Artificial Intelligence | Madhu Jahagirdar

Radiologists spend much of their day moving between different systems: One application to review images. Another to ...

Time August 17, 2026
arrow
News | X-Ray

Aug. 10, 2026 — Teledyne Technologies Inc. and Varex Imaging Corp. have jointly announced that they have entered into a ...

Time August 14, 2026
arrow
News | Breast Imaging

Aug. 13, 2026 – Perimeter Medical Imaging AI recently announced that Intermountain Health, the largest nonprofit health ...

Time August 14, 2026
arrow
News | FDA

Aug. 1, 2026 — Candelis recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Time August 13, 2026
arrow
News | Artificial Intelligence

Aug. 10, 2026 — OSF HealthCare, a not-for-profit health system serving communities across Illinois and Michigan, and ...

Time August 12, 2026
arrow
News | Lung Imaging

Aug. 11, 2026 — Noah Medical has launched the Galaxy II software, the next evolution of its robotic-assisted ...

Time August 10, 2026
arrow
News | Radiology Business

Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...

Time August 10, 2026
arrow
News | Radiology Imaging

Aug. 4, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that the time between an imaging scan ...

Time August 06, 2026
arrow
News | Contrast Agents

Aug. 5, 2026 — Bracco Group is bringing a newly authorized macrocyclic gadolinium-based contrast agent (GBCA) for ...

Time August 05, 2026
arrow
Subscribe Now